This well-conducted review concluded that endoscopic sinus surgery may offer some advantages in effectiveness over comparator techniques in the removal of nasal polyps. However, the authors also highlighted the enormous variation in the results of the included studies and their severe methodological limitations.
Study selection Study designs of evaluations included in the review
Comparative studies and case series were eligible for inclusion. Case series were required to examine more than 50 patients with nasal polyps. The following study types were excluded: narrative reviews, editorials, single case studies or reports, expert opinion papers and preclinical or biological studies. Reviews published over 5 years ago were also excluded. The included studies reported follow-up ranging from 6 to 42 months.
Specific interventions included in the review
Studies examining functional endoscopic sinus surgery (FESS) in the excision of nasal polyps were eligible for inclusion. Comparative studies were required to compare FESS with conventional procedures. Studies assessing only the pathology or histology of polyps were excluded. The included studies examined the effectiveness of the procedure carried out both under general and local anaesthetic. Where reported, post-operative management involved the use of either topical or systemic steroids.
Participants included in the review
Studies adequately describing the patient population in terms of surgical indications and numbers of patients with polyps were eligible for inclusion. Studies detailing animal models were excluded. The majority of the included studies examined patients with a variety of disease including polyps; a selection focused only on patients with polyps. Both adults and children were examined in the primary studies. The majority of the studies were conducted in the USA or Europe.
Outcomes assessed in the review
Studies reporting patient-relevant outcomes were eligible for inclusion. Those only reporting on the histological appearance of polyps, mean blood loss, or duration of surgery were excluded. The data were required to be presented in such a way that the results of nasal polyp excisions could be isolated from procedures for other conditions. Symptomatic improvement was chosen as the primary outcome measure of the review; revision rates, recurrence or residual disease, and complications were also reported in detail.
How were decisions on the relevance of primary studies made?
Two reviewers screened potentially relevant studies independently. Where necessary, disagreements were resolved by consensus. Decisions were made prior to data extraction and detailed examination of the study results.
Assessment of study quality
The internal validity (reflected in the study's sample size and potential for selection, performance, detection or attrition bias) and external validity (defined in terms of generalisability, patient characteristics, usual care setting, standard treatment regime, standard treatment outcomes, and length of follow-up) of comparative studies were assessed using structured forms. Similarly, the internal validity and external validity of case series were assessed, with reference to sample size, and potential for selection, performance and attrition bias, as well as generalisability, patient characteristics, usual care setting, standard surgical regime, standard treatment outcomes, and length of follow-up. The quality of the included studies was assessed by one reviewer and checked by a second reviewer.
Data extraction
The data were extracted by one reviewer and checked for accuracy by a second reviewer. Any disagreements were resolved by consensus. In addition to extracting the reported study results, the reviewers calculated results on an intention-to-treat basis using original data where available.
Methods of synthesis
How were the studies combined?
The results of the included studies were synthesised in narrative form. The results were also presented in forest plots, but were not combined.
How were differences between studies investigated?
Differences between the studies were highlighted in the ordering of the results according to primacy of outcome measure, rigour of study design and the proportion of patients with polyps.
Results of the review
Thirty-three studies (n=11,147) were included in this review: 3 randomised controlled trials (RCTs; n=240), 3 controlled clinical trials (CCTs; n=2,699) and 27 case series reports (n=8,208).
Symptomatic improvement (5 RCTs/CCTs).
Three trials reported greater symptomatic improvement for FESS techniques, with the improvement ranging from 78 to 85% compared with 43 to 72% for comparative techniques. Two of these studies displayed statistically significant differences. A further trial reported no difference between the techniques (82%). Another trial reported that radical nasalisation showed greater improvement than conventional ethmoidectomy (41% versus 8%); the differences were statistically significant.
Symptomatic improvement (case series).
For participants with nasal polyps, symptomatic improvement ranged from 37 to 99% (n=10). In the mixed patient group (with and without nasal polyps), overall symptomatic improvement ranged from 40 to 98% (n=17).
Recurrence of polyps or disease (2 RCTs/CCTs).
In the one trial that reported disease recurrence, the rates were not significantly different between FESS and Caldwell-Luc techniques (8% versus 14%). A different trial reported no significant differences in polyp recurrence between endoscopic ethmoidectomy and polypectomy (28% versus 35%).
